APOE and Alzheimer disease: As AD progresses in the APOE ε3 genotype, metabolites linked to oxidative DNA damage, changes in inhibitory neurotransmitters, disruptions of neuronal membranes, and decreases in metabolites related to acetylcholine synthesis were correlated best with the differences between early- and late-stage AD.